\-\ Texto\\:\\ \ \(0\)\
\-\ hemoccult\\ stool\\ testing\\ was\\ positive\\ for\\ blood\ \(0\)\
\-\ due\\ to\\ the\\ metastatic\\ disease\\,\\ chemotherapy\\ is\\ ongoing\\.\\ \\ diverting\\ colostomy\\ was\\ performed\\ as\\ well\\.\ \(0\)\
\-\ axial\\ ct\\ images\\ demonstrate\\ abnormal\\ pericolonic\\ soft\\-tissue\\ stranding\\ and\\ nodularity\\.\\ \\ abnormal\\ lymph\\ nodes\\ are\\ seen\\ in\\ the\\ colonic\\ mesentery\\.\\ \\ hypoattenuating\\ enhancing\\ liver\\ lesions\\ are\\ noted\\.\\ \\ gi\\ fluoroscopy\\ \\(single\\ contrast\\ enema\\)\\ reveals\\ a\\ constricting\\ submucosal\\ lesion\\ near\\ the\\ hepatic\\ flexure\\.\ \(0\)\
\-\ colon\\ cancer\ \(55\)\
\-\ colon\\ cancer\ \(55\)\
\-\ focal\\ colonic\\ infection\ \(0\)\
\-\ ischemia\ \(171\)\
\-\ 61\\ y\\.o\\.\\ man\\ with\\ intermittent\\ lower\\ abdominal\\ pain\\ and\\ constipation\\;\\ the\\ patient\\ has\\ never\\ had\\ an\\ optical\\ colonoscopy\\ screenng\\ exam\\ \\(he\\ refused\\ further\\ testing\\ after\\ a\\ bad\\ experience\\ with\\ a\\ flexible\\ sigmoidoscopy\\)\\.\ \(1\)\
\-\ colon\\ cancer\\ screening\\ with\\ optical\\ colonoscopy\\ is\\ underutilized\\ \\(many\\ patients\\ do\\ not\\ get\\ this\\ test\\ due\\ to\\ fear\\ of\\ the\\ exam\\,\\ financial\\ contraints\\,\\ access\\ problems\\,\\ etc\\)\\.\\ \\ as\\ ct\\ colonography\\ \\(ctc\\)\\ continues\\ to\\ gain\\ favor\\,\\ finding\\ pre\\-malignant\\ adenomatous\\ polyps\\ before\\ they\\ become\\ malignant\\ colon\\ cancers\\ is\\ important\\ if\\ we\\ are\\ to\\ decrease\\ mortality\\ from\\ colon\\ cancer\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ colon\\:\\ 0\\.32311488994581783\ \(0\)\
\-\ optical\\:\\ 0\\.24419184063220545\ \(0\)\
\-\ cancer\\:\\ 0\\.22612317266511803\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.17688880778014696\ \(0\)\
\-\ colonic\\:\\ 0\\.1656617053260742\ \(0\)\
\-\ testing\\:\\ 0\\.15248378858901487\ \(0\)\
\-\ screenng\\:\\ 0\\.13572890099188095\ \(0\)\
\-\ underutilized\\:\\ 0\\.13572890099188095\ \(0\)\
\-\ contraints\\:\\ 0\\.13572890099188095\ \(0\)\
\-\ financial\\:\\ 0\\.12969621093920003\ \(0\)\
\-\ ctc\\:\\ 0\\.12969621093920003\ \(0\)\
\-\ sigmoidoscopy\\:\\ 0\\.1254159492295993\ \(0\)\
\-\ hemoccult\\:\\ 0\\.12209592031610272\ \(0\)\
\-\ malignant\\:\\ 0\\.12099965816884571\ \(0\)\
\-\ fear\\:\\ 0\\.1193832591769184\ \(0\)\
\-\ colonography\\:\\ 0\\.1170897368633786\ \(0\)\
\-\ diverting\\:\\ 0\\.11510299746731768\ \(0\)\
\-\ constricting\\:\\ 0\\.11510299746731768\ \(0\)\
\-\ flexible\\:\\ 0\\.11510299746731768\ \(0\)\
\-\ refused\\:\\ 0\\.1117829685538211\ \(0\)\
\-\ bad\\:\\ 0\\.1117829685538211\ \(0\)\
\-\ colostomy\\:\\ 0\\.10787939644174245\ \(0\)\
\-\ pericolonic\\:\\ 0\\.10677678510109696\ \(0\)\
\-\ abnormal\\:\\ 0\\.10197999462677068\ \(0\)\
\-\ favor\\:\\ 0\\.10147001679153946\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.10005194958396263\ \(0\)\
\-\ gain\\:\\ 0\\.10005194958396263\ \(0\)\
\-\ adenomatous\\:\\ 0\\.09814998787804285\ \(0\)\
\-\ due\\:\\ 0\\.0975721009847004\ \(0\)\
\-\ are\\:\\ 0\\.0966152606845648\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.09543732673885853\ \(0\)\
\-\ access\\:\\ 0\\.0949494651842691\ \(0\)\
\-\ ongoing\\:\\ 0\\.09447709394275441\ \(0\)\
\-\ nodularity\\:\\ 0\\.09401925953128171\ \(0\)\
\-\ submucosal\\:\\ 0\\.09401925953128171\ \(0\)\
\-\ flexure\\:\\ 0\\.09272466559967421\ \(0\)\
\-\ mesentery\\:\\ 0\\.0923170114865755\ \(0\)\
\-\ constipation\\:\\ 0\\.0923170114865755\ \(0\)\
\-\ get\\:\\ 0\\.0923170114865755\ \(0\)\
\-\ polyps\\:\\ 0\\.09153375462677989\ \(0\)\
\-\ cancers\\:\\ 0\\.09115706502925781\ \(0\)\
\-\ never\\:\\ 0\\.08940463668617761\ \(0\)\
\-\ 61\\:\\ 0\\.08615088157653368\ \(0\)\
\-\ enema\\:\\ 0\\.08562877732704936\ \(0\)\
\-\ exam\\:\\ 0\\.08544927513036106\ \(0\)\
\-\ to\\:\\ 0\\.08487139336227541\ \(0\)\
\-\ the\\:\\ 0\\.08467525662386993\ \(0\)\
\-\ stool\\:\\ 0\\.08463651342198746\ \(0\)\
\-\ experience\\:\\ 0\\.08439845323345348\ \(0\)\
\-\ etc\\:\\ 0\\.08348256754727351\ \(0\)\
\-\ mortality\\:\\ 0\\.08348256754727351\ \(0\)\
\-\ we\\:\\ 0\\.08160727769378665\ \(0\)\
\-\ continues\\:\\ 0\\.08103126597821249\ \(0\)\
\-\ stranding\\:\\ 0\\.07597136967161294\ \(0\)\
\-\ become\\:\\ 0\\.07531582556476772\ \(0\)\
\-\ problems\\:\\ 0\\.07362051224140095\ \(0\)\
\-\ ischemia\\:\\ 0\\.07350650061558474\ \(0\)\
\-\ decrease\\:\\ 0\\.07294919035538429\ \(0\)\
\-\ nodes\\:\\ 0\\.07209876207511093\ \(0\)\
\-\ important\\:\\ 0\\.07189353889916512\ \(0\)\
\-\ gi\\:\\ 0\\.071294325931505\ \(0\)\
\-\ do\\:\\ 0\\.07034633373203072\ \(0\)\
\-\ is\\:\\ 0\\.06972837093725248\ \(0\)\
\-\ intermittent\\:\\ 0\\.06936889047204763\ \(0\)\
\-\ near\\:\\ 0\\.06911309429711772\ \(0\)\
\-\ test\\:\\ 0\\.06902879693641001\ \(0\)\
\-\ screening\\:\\ 0\\.06894497449292993\ \(0\)\
\-\ before\\:\\ 0\\.06861432878867682\ \(0\)\
\-\ as\\:\\ 0\\.06819223746336744\ \(0\)\
\-\ hepatic\\:\\ 0\\.06758782218872002\ \(0\)\
\-\ many\\:\\ 0\\.06691650030270337\ \(0\)\
\-\ lymph\\:\\ 0\\.0659973492934851\ \(0\)\
\-\ single\\:\\ 0\\.06526163587882408\ \(0\)\
\-\ ct\\:\\ 0\\.06462318034512195\ \(0\)\
\-\ reveals\\:\\ 0\\.06456059448324504\ \(0\)\
\-\ they\\:\\ 0\\.060642663247293935\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.060264777681412675\ \(0\)\
\-\ was\\:\\ 0\\.05915750651840197\ \(0\)\
\-\ liver\\:\\ 0\\.058548669883152424\ \(0\)\
\-\ positive\\:\\ 0\\.05592632878632993\ \(0\)\
\-\ finding\\:\\ 0\\.05578760102729429\ \(0\)\
\-\ further\\:\\ 0\\.05527859662161521\ \(0\)\
\-\ enhancing\\:\\ 0\\.05316728118910682\ \(0\)\
\-\ infection\\:\\ 0\\.05126763537460186\ \(0\)\
\-\ focal\\:\\ 0\\.050766630317068996\ \(0\)\
\-\ he\\:\\ 0\\.05025812300192313\ \(0\)\
\-\ performed\\:\\ 0\\.050210587995469035\ \(0\)\
\-\ with\\:\\ 0\\.04985703134558774\ \(0\)\
\-\ if\\:\\ 0\\.049312776094368765\ \(0\)\
\-\ blood\\:\\ 0\\.049290452842822664\ \(0\)\
\-\ axial\\:\\ 0\\.049025154086639655\ \(0\)\
\-\ lesions\\:\\ 0\\.04874298694748436\ \(0\)\
\-\ patients\\:\\ 0\\.047745175523952375\ \(0\)\
\-\ metastatic\\:\\ 0\\.0465480793735155\ \(0\)\
\-\ abdominal\\:\\ 0\\.046418781091693485\ \(0\)\
\-\ noted\\:\\ 0\\.04499904205487007\ \(0\)\
\-\ man\\:\\ 0\\.04493232246161003\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04412263170224602\ \(0\)\
\-\ lower\\:\\ 0\\.04336971549565884\ \(0\)\
\-\ had\\:\\ 0\\.04228638091568574\ \(0\)\
\-\ contrast\\:\\ 0\\.04123760119126345\ \(0\)\
\-\ after\\:\\ 0\\.04117282771340667\ \(0\)\
\-\ well\\:\\ 0\\.04109546994279144\ \(0\)\
\-\ lesion\\:\\ 0\\.04068955370178942\ \(0\)\
\-\ seen\\:\\ 0\\.03995707875877596\ \(0\)\
\-\ images\\:\\ 0\\.039258978343526874\ \(0\)\
\-\ has\\:\\ 0\\.038767084143740124\ \(0\)\
\-\ disease\\:\\ 0\\.035626275776837135\ \(0\)\
\-\ and\\:\\ 0\\.03507554431896703\ \(0\)\
\-\ from\\:\\ 0\\.03370758411747873\ \(0\)\
\-\ not\\:\\ 0\\.0335054704799622\ \(0\)\
\-\ an\\:\\ 0\\.03245479093502217\ \(0\)\
\-\ pain\\:\\ 0\\.030370346549731225\ \(0\)\
\-\ this\\:\\ 0\\.029163568311965163\ \(0\)\
\-\ patient\\:\\ 0\\.027604620515485217\ \(0\)\
\-\ for\\:\\ 0\\.025724070086560493\ \(0\)\
\-\ in\\:\\ 0\\.021113414134980246\ \(0\)\
\-\ of\\:\\ 0\\.01660908652328931\ \(0\)\
